Bioorganic & Medicinal Chemistry Letters 2005-10-01

4-Phenyl-1,2,3,6-tetrahydropyridine, an excellent fragment to improve the potency of PARP-1 inhibitors.

Junya Ishida, Kouji Hattori, Hirofumi Yamamoto, Akinori Iwashita, Kayoko Mihara, Nobuya Matsuoka

Index: Bioorg. Med. Chem. Lett. 15(19) , 4221-5, (2005)

Full Text: HTML

Abstract

We have shown that a 4-phenyl-1,2,3,6-tetrahydropyridine fragment plays an important role in improving inhibitory potency against poly(ADP-ribose) polymerase-1 (PARP-1). Various benzamide analogues linked with this fragment via alkyl spacers have been prepared and evaluated. As a result, some of them have been found to be highly potent PARP-1 inhibitors.


Related Compounds

Related Articles:

Polygalae radix inhibits toxin-induced neuronal death in the Parkinson's disease models.

2011-03-24

[J. Ethnopharmacol. 134(2) , 414-21, (2011)]

Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

2009-01-01

[PLoS ONE 4(9) , e7247, (2009)]

Neuroprotective effects of an herbal medicine, Yi-Gan San on MPP+/MPTP-induced cytotoxicity in vitro and in vivo.

2010-09-15

[J. Ethnopharmacol. 131(2) , 433-42, (2010)]

Inhibition of dihydropteridine reductase by novel 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs.

1984-04-27

[Science 224(4647) , 405-7, (1984)]

4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.

1987-03-20

[Neurosci. Lett. 75(1) , 65-70, (1987)]

More Articles...